News
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
5d
Zacks.com on MSNVertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should KnowZacks.com users have recently been watching Vertex (VRTX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Want to invest in artificial intelligence (AI), cloud computing, digital media, and e-commerce in one fell swoop? You could ...
Janus Henderson Investors, an investment management company, released its “Janus Henderson Venture Fund” first quarter 2025 ...
Vertex Pharmaceuticals (NasdaqGS:VRTX) recently received approval from the European Commission for ALYFTREK, enhancing its reach in European markets with new reimbursement agreements in Ireland and ...
Buying $100 In VRTX: If an investor had bought $100 of VRTX stock 10 years ago, it would be worth $345.57 today based on a price of $445.20 for VRTX at the time of writing.
There are many promising corporations that investors can buy on a dip due to recent market volatility or company-specific ...
2d
Clinical Trials Arena on MSNVertex reports long-term results for Casgevy in sickle cell and thalassaemiaAcross 100 patients in three Phase III studies, Vertex's Casgevy showed lasting benefits for more than five years.
Spain is investigating Novo Nordisk over concerns it may be illegally advertising its weight loss drugs Ozempic and Wegovy ...
Two growth stocks in the healthcare industry stand out in particular. Here is what you need to know about each one and why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results